Literature DB >> 21430107

Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii.

Céline Damiani1, Solène Le Gal, Delphine Lejeune, Naima Brahimi, Michèle Virmaux, Gilles Nevez, Anne Totet.   

Abstract

This article describes positive (1 → 3)-β-D-glucan levels in serum from infants with primary Pneumocystis infection and from immunosuppressed patients with Pneumocystis pneumonia (PCP) and negative levels in serum from patients colonized by Pneumocystis jirovecii. Glucan detection is a complementary tool for the diagnosis of the diverse clinical presentations of P. jirovecii infection.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21430107      PMCID： PMC3122691          DOI： 10.1128/JCM.00249-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  β-D-glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study.

Authors:  Mark G J de Boer; Luc B S Gelinck; Bertrand D van Zelst; Wendy W J van de Sande; Luuk N A Willems; Jaap T van Dissel; Robert de Jonge; Frank P Kroon
Journal:  J Infect       Date:  2010-10-21       Impact factor: 6.072

2.  (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia.

Authors:  Francisco M Marty; Sophia Koo; Julie Bryar; Lindsey R Baden
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

3.  Use of a serum (1-->3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia.

Authors:  María Soledad Cuétara; Almudena Alhambra; Fernando Chaves; María Dolores Moragues; José Pontón; Amalia del Palacio
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

Review 4.  Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility.

Authors:  Malcolm A Finkelman
Journal:  Crit Rev Microbiol       Date:  2010-11       Impact factor: 7.624

5.  Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.

Authors:  Hideta Nakamura; Masao Tateyama; Daisuke Tasato; Syusaku Haranaga; Satomi Yara; Futoshi Higa; Yuji Ohtsuki; Jiro Fujita
Journal:  Intern Med       Date:  2009-02-16       Impact factor: 1.271

6.  Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Florence Persat; Stéphane Ranque; Francis Derouin; Annie Michel-Nguyen; Stéphane Picot; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

7.  Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.

Authors:  Valerio Del Bono; Alessandra Mularoni; Elisa Furfaro; Emanuele Delfino; Lorenzo Rosasco; Franca Miletich; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

8.  Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy.

Authors:  Stefanie Desmet; Eric Van Wijngaerden; Johan Maertens; Jan Verhaegen; Eric Verbeken; Paul De Munter; Wouter Meersseman; Britt Van Meensel; Johan Van Eldere; Katrien Lagrou
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

9.  Serum (1-->3) beta-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS.

Authors:  Tamayo Watanabe; Akira Yasuoka; Junko Tanuma; Hirohisa Yazaki; Haruhito Honda; Kunihisa Tsukada; Miwako Honda; Hiroyuki Gatanaga; Katsuji Teruya; Yoshimi Kikuchi; Shinichi Oka
Journal:  Clin Infect Dis       Date:  2009-10-01       Impact factor: 9.079

10.  Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.

Authors:  Yasuo Shimizu; Noriaki Sunaga; Kunio Dobashi; Makoto Fueki; Naoto Fueki; Sohei Makino; Masatomo Mori
Journal:  BMC Infect Dis       Date:  2009-04-22       Impact factor: 3.090
View more
  10 in total

1.  The Fascinating Echinocandin-Treated Mouse Model of Pneumocystis murina To Understand Pneumocystis jirovecii.

Authors:  Gilles Nevez; Anne Totet; Céline Damiani; Solène Le Gal
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

2.  Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Authors:  Céline Damiani; Solène Le Gal; Cécilia Da Costa; Michèle Virmaux; Gilles Nevez; Anne Totet
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

3.  (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Authors:  F Esteves; C-H Lee; B de Sousa; R Badura; M Seringa; C Fernandes; J F Gaspar; F Antunes; O Matos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-03       Impact factor: 3.267

4.  Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.

Authors:  Valerio Del Bono; Emanuele Delfino; Elisa Furfaro; Malgorzata Mikulska; Elena Nicco; Paolo Bruzzi; Alessandra Mularoni; Matteo Bassetti; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

5.  Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.

Authors:  Michael J Linke; Alan Ashbaugh; Margaret S Collins; Keeley Lynch; Melanie T Cushion
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

6.  Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.

Authors:  Florence Robert-Gangneux; Sorya Belaz; Matthieu Revest; Pierre Tattevin; Stéphane Jouneau; Olivier Decaux; Sylviane Chevrier; Yves Le Tulzo; Jean-Pierre Gangneux
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

7.  Detection of (1, 3)-β-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts.

Authors:  Elitza S Theel; Deborah J Jespersen; Seher Iqbal; Jean E Bestrom; Leonard O Rollins; Lori J Misner; Barbara J Markley; Jayawant Mandrekar; Larry M Baddour; Andrew H Limper; Nancy L Wengenack; Matthew J Binnicker
Journal:  Mycopathologia       Date:  2012-09-01       Impact factor: 2.574

8.  Utility of adding Pneumocystis jirovecii DNA detection in nasopharyngeal aspirates in immunocompromised adult patients with febrile pneumonia.

Authors:  Nicolas Guigue; Alexandre Alanio; Jean Menotti; Nathalie De Castro; Samia Hamane; Olivier Peyrony; Jérôme LeGoff; Stéphane Bretagne
Journal:  Med Mycol       Date:  2014-12-30       Impact factor: 4.076

Review 9.  Pneumocystis Pneumonia in Solid-Organ Transplant Recipients.

Authors:  Xavier Iriart; Marine Le Bouar; Nassim Kamar; Antoine Berry
Journal:  J Fungi (Basel)       Date:  2015-09-28

10.  Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.

Authors:  Petra Rogina; Miha Skvarc
Journal:  Radiol Oncol       Date:  2020-05-28       Impact factor: 2.991
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.